Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Stephen Melnick, Priya Rajagopalan, Theresa Lynn & Anthony Donato. (2018) Perioperative genitourinary infection associated with sodium-glucose co-transporter 2 inhibitor use. Journal of Community Hospital Internal Medicine Perspectives 8:5, pages 315-316.
Read now
Read now
Rizwana Parveen, Nidhi Bharal Agarwal, Neelam Kaushal, Ghanshyam Mali & Sheikh Raisuddin. (2016) Efficacy and safety of canagliflozin in type 2 diabetes mellitus: systematic review of randomized controlled trials. Expert Opinion on Pharmacotherapy 17:1, pages 105-115.
Read now
Read now
Articles from other publishers (17)
Nisha C. Patel & Hitesh A. Patel. (2022) A recent solidification approach for nanosuspension: formulation, optimisation and evaluation of canagliflozin immediate release pellets. Folia Medica 64:3, pages 488-500.
Crossref
Crossref
John C. Clapham. 2020. Type 2 Diabetes. Type 2 Diabetes
1
30
.
Aleksandra Pałasz, Dariusz Cież, Bartosz Trzewik, Katarzyna Miszczak, Grzegorz Tynor & Bartłomiej Bazan. (2019) In the Search of Glycoside-Based Molecules as Antidiabetic Agents. Topics in Current Chemistry 377:4.
Crossref
Crossref
. 2019. Diabetologie. Diabetologie
141
252
.
Priyanka A. Shah & Pranav S. Shrivastav. (2018) Ion-pair solid phase extraction for the simultaneous separation and quantitation of metformin and canagliflozin in human plasma by LC-MS/MS. Microchemical Journal 143, pages 181-189.
Crossref
Crossref
YL Shao, KH Yee, SK, Koh, YF Wong, LY Yeoh, S Low & CF Sum. (2018) Short-term outcomes of patients with Type 2 diabetes mellitus treated with canagliflozin compared with sitagliptin in a real-world setting. Singapore Medical Journal 59:5, pages 251-256.
Crossref
Crossref
Andrew J. Krentz & Alan J. Sinclair. 2017. Diabetes in Old Age. Diabetes in Old Age
298
322
.
Éva Bokor, Sándor Kun, David Goyard, Marietta Tóth, Jean-Pierre Praly, Sébastien Vidal & László Somsák. (2017)
C
-Glycopyranosyl Arenes and Hetarenes: Synthetic Methods and Bioactivity Focused on Antidiabetic Potential
. Chemical Reviews 117:3, pages 1687-1764.
Crossref
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
419
458
.
Grabner Michael, Peng Xiaomei, Caroline Geremakis & Jay Bae. (2015) Demographic and Clinical Profiles of Type 2 Diabetes Mellitus Patients Initiating Canagliflozin Versus DPP-4 Inhibitors in a Large U.S. Managed Care Population. Journal of Managed Care & Specialty Pharmacy 21:12, pages 1204-1212.
Crossref
Crossref
Xiang-Yang Liu, Ning Zhang, Rui Chen, Jia-Guo Zhao & Pei Yu. (2015) Efficacy and safety of sodium–glucose cotransporter 2 inhibitors in type 2 diabetes: a meta-analysis of randomized controlled trials for 1 to 2 years. Journal of Diabetes and its Complications 29:8, pages 1295-1303.
Crossref
Crossref
Ozra Tabatabaei-Malazy, Bagher Larijani & Mohammad Abdollahi. (2015) Targeting metabolic disorders by natural products. Journal of Diabetes & Metabolic Disorders 14:1.
Crossref
Crossref
Jean-Daniel Lalau, Paul Arnouts, Adnan Sharif & Marc E. De Broe. (2015) Metformin and other antidiabetic agents in renal failure patients. Kidney International 87:2, pages 308-322.
Crossref
Crossref
Yasuhiko Kubota, Hiroyasu Iso, Satoyo Ikehara & Akiko Tamakoshi. (2015) Relationship between sleep duration and cause-specific mortality in diabetic men and women based on self-reports. Sleep and Biological Rhythms 13:1, pages 85-93.
Crossref
Crossref
L. Monnier & C. Colette. (2015) Impact des inhibiteurs du cotransporteur sodium-glucose de type 2 (SGLT2) sur la glycémie post-prandiale. Médecine des Maladies Métaboliques 9:1, pages S17-S25.
Crossref
Crossref
Matt Hrapchak, Bachir Latli, Xiao-Jun Wang, Heewon Lee, Scot Campbell, Jinhua J. Song & Chris H. Senanayake. (2014) Synthesis of empagliflozin, a novel and selective sodium-glucose co-transporter-2 inhibitor, labeled with carbon-14 and carbon-13. Journal of Labelled Compounds and Radiopharmaceuticals 57:12, pages 687-694.
Crossref
Crossref
Yoshihito Fujita & Nobuya Inagaki. (2014) Renal sodium glucose cotransporter 2 inhibitors as a novel therapeutic approach to treatment of type 2 diabetes: Clinical data and mechanism of action. Journal of Diabetes Investigation 5:3, pages 265-275.
Crossref
Crossref